https://www.selleckchem.com/products/lee011.html
The ability of pathogenic bacteria to survive antimicrobial peptides (AMPs) in various host niches may contribute to their virulence. Polymyxin B is a cationic AMP, and polymyxin drugs are considered to be the "last line of defense" in the clinical treatment of bacterial infections. The objectives of this study were to comprehensively study the response of Brucella melitensis strain NI to polymyxin B treatment and to identify the target genes in Brucella induced by polymyxin B stimulation. Following treatment with polymyxin B, differenti
Curtir
Comentario
Compartilhar
